Related Experiment Videos

Quality of life in children requiring antithrombotic therapy: development of a measure

Aisha A K Bruce1, Mary E Bauman, M Patricia Massicotte

  • 1Division of Cardiology, Vascular Patency and Thrombosis Program, University of Alberta, Stollery Children's Hospital, Edmonton, Alberta, Canada.

Seminars in Thrombosis and Hemostasis
|December 22, 2011
PubMed

Insights

Developing a pediatric quality of life (QOL) inventory is crucial for children on long-term antithrombotic therapy. This tool will measure health-related quality of life (HRQOL) and guide treatment decisions.

Area of Science:

  • Pediatric Health Outcomes
  • Clinical Trial Methodology
  • Patient-Centered Care

Background:

  • Quality of life (QOL) is a key outcome in clinical trials.
  • Long-term antithrombotic therapy may negatively impact patient satisfaction and QOL.
  • Health-related quality of life (HRQOL) measurement requires condition-specific tools.

Purpose of the Study:

  • To highlight the necessity of a pediatric QOL inventory for children on long-term antithrombotic therapy.
  • To emphasize the need for rigorous development of HRQOL measurement tools.
  • To underscore the importance of patient-centered outcomes in clinical research.

Main Methods:

  • Identification and evaluation of QOL constructs relevant to pediatric antithrombotic therapy.
  • Adherence to rigorous methodological standards for inventory creation.
  • Ensuring the inventory is valid and reliable for measuring HRQOL changes.

Main Results:

  • A specific HRQOL inventory is essential for upcoming clinical trials.
  • This inventory will measure changes in HRQOL related to antithrombotic agents.
  • It will provide data for informed therapeutic choices and research strategies.

Conclusions:

  • A validated pediatric HRQOL inventory is critical for antithrombotic therapy trials.
  • Such a tool will enhance patient care by informing treatment decisions.
  • It will also guide future research and policy development in pediatric antithrombotic therapy.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...